Tresiba and Metabolic encephalopathy - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Tresiba?
Tresiba has active ingredients of insulin degludec. It is used in type 1 diabetes. Currently, eHealthMe is studying from 18,888 Tresiba users.
What is Metabolic Encephalopathy?
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy) is found to be associated with 1,196 drugs and 567 conditions by eHealthMe. Currently, we are studying 3,251 people who have Metabolic encephalopathy.
Do you take Tresiba and have Metabolic encephalopathy?Check whether Metabolic encephalopathy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Tresiba side effects by duration, gender and age:
- Tresiba side effects (18,888 reports)
Metabolic encephalopathy treatments and more:
- Metabolic encephalopathy (3,251 reports)
All the drugs that are associated with Metabolic encephalopathy:
All the conditions that are associated with Metabolic encephalopathy:
How the study uses the data?
The study uses data from the FDA. It is based on insulin degludec (the active ingredients of Tresiba) and Tresiba (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tylenol and Bronchospasm Aggravated - 29 seconds ago
- Lasix and Phlebitis Superficial - 40 seconds ago
- Tamsulosin and Peripheral Sensory Neuropathy - 42 seconds ago
- Furosemide and Diclofenac Sodium drug interaction - 50 seconds ago
- Kerlone and Fatigue - 55 seconds ago
- Colace and Large Intestinal Obstruction - 59 seconds ago
- Phentermine and Skin Discoloration - Bluish - a minute ago
- Flovent and Infusion Site Pruritus - a minute ago
- Avelox and Angioedema - a minute ago
- Azulfidine En-Tabs and Oculomucocutaneous Syndrome - 2 minutes ago